Spotlight
Video

Will Resistance be a Problem for New CLL Drugs?

patientpower has 2230 videos Subscribe Here

Loading........
Description: There's now some early evidence that not everyone responds well or long-term to one of the promising new drugs for CLL, Ibrutinib. The problem is a patient's cancer cells become resistant to the medicine. This has happened before and in other leukemias. Dr. Jeff Sharman from US Oncology reports on the news from a meeting of world CLL experts and puts this new story of resistance in perspective.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://bit.ly/patientpowerY...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Shared By : patientpower
Posted on : 09/23/13
Added : 4 years ago
Category : Other